
QuartzBio is a life science technology company delivering connected sample and biomarker intelligence for clinical-stage biopharma. Designed for modern, multi-trial portfolios, its vendor‑agnostic platform unifies sample operations and biomarker data into a single platform—powered by domain‑specific AI agents—to reduce operational risk, accelerate timelines, and enable scientifically defensible outcomes.